People living with severe, symptomatic aortic stenosis face a serious heart condition where the aortic valve becomes narrow and stiff. This makes it harder for blood to flow from the heart to the rest of the body. Patients with this condition often need treatment to improve their quality of life and manage their symptoms. For many years, doctors have used two main methods to treat this: traditional open-heart surgery or a less invasive procedure called TAVR (transcatheter aortic valve replacement). This study looks at which of these two options provides better long term results for patients who are at an intermediate risk for surgery.
To find the answer, researchers conducted a large randomized trial involving 1,910 patients across 57 different centers. The participants were divided into two groups: one group received the TAVR procedure using a specific balloon-expandable system, and the other group underwent traditional surgery. Because of the large size of the study and the long follow up period of 10 years, it provided a significant amount of data regarding how these treatments perform over a decade rather than just a few months.
The results showed that patients who underwent surgery had a lower rate of all-cause mortality compared to those who received TAVR. Specifically, the mortality rate was about 82.8 percent for the surgery group versus 86.1 percent for the TAVR group. The study also found that patients who received TAVR were more likely to need another procedure on their heart valve within 10 years compared to those who had surgery. However, the researchers noted that these differences in survival were most noticeable in a specific group of TAVR patients who had their procedure through certain access points.
It is important to note some limitations in this data. Only a small number of patients in both groups had available heart scans at the 10-year mark, which means the researchers could not compare the physical condition of the valves as clearly as they might have liked. Additionally, while the study shows a link between the type of procedure and survival rates, it does not mean that TAVR is inherently unsafe or ineffective for everyone. For patients today, this means that the choice between surgery and TAVR involves many factors. While TAVR is often less invasive in the short term, this study suggests that surgery may offer more durable results over a 10-year period for certain types of patients. Patients should talk to their heart specialists to discuss their specific risk factors and determine which treatment path offers the best long-term outlook for their individual health needs.
